{"id":653773,"date":"2023-05-31T13:00:07","date_gmt":"2023-05-31T13:00:07","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=653773"},"modified":"2023-05-31T13:00:07","modified_gmt":"2023-05-31T13:00:07","slug":"peptic-ulcers-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-study-period-20192032-key-companies-astrazeneca-cgbio-inc-ucb-pharmaceuticals-pfizer","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/peptic-ulcers-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-study-period-20192032-key-companies-astrazeneca-cgbio-inc-ucb-pharmaceuticals-pfizer_653773.html","title":{"rendered":"Peptic Ulcers Market is Expected to Expand at a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies – AstraZeneca, CGBio Inc, UCB Pharmaceuticals, Pfizer"},"content":{"rendered":"
\n
DelveInsight Business Research LLP <\/div>\n<\/div>\n
DelveInsight\u2019s \u201cPeptic Ulcer \u2013 Market Insights, Epidemiology, and Market Forecast \u2013 2032\u201d report delivers an in-depth understanding of the peptic ulcer, historical and forecasted epidemiology as well as the peptic ulcer market trends in the United States, EU4 (Germany, France, Italy, Spain) and United Kingdom, and Japan.<\/div>\n

DelveInsight’s ” Peptic Ulcer – Market Insights, Epidemiology, and Market Forecast – 2032<\/a>“<\/strong> report delivers an in-depth understanding of the Peptic Ulcers epidemiology insights, Peptic Ulcers market trends, therapies, and key companies working in the Peptic Ulcers  Market in the 7MM.<\/p>\n

Peptic Ulcers Overview<\/strong><\/p>\n

Peptic Ulcer disease is a condition in which painful sores or ulcers develop in the lining of the stomach or the first part of the small intestine (the duodenum). Normally, a thick layer of mucus protects the stomach lining from the effect of its digestive juices. But many things can reduce this protective layer, allowing stomach acid to damage the tissue. People of any age who take NSAIDs every day or multiple times per week are more likely to develop a peptic ulcer than people who do not take them regularly. People of any age who take NSAIDs every day or multiple times per week are more likely to develop a peptic ulcer than people who do not take them regularly In uncomplicated peptic ulcer disease, the clinical findings are few and nonspecific. Patients with perforated peptic ulcer disease usually present with a sudden onset of severe, sharp abdo. “Alarm features” that warrant prompt gastroenterology referral include bleeding, anemia, early satiety, unexplained weight loss, progressive dysphagia or odynophagia, recurrent vomiting, and a family history of gastrointestinal (GI) conterminal pain. In most patients with uncomplicated peptic ulcer disease, routine laboratory tests usually are not helpful; instead, documentation of peptic ulcer disease depends on radiographic and endoscopic confirmation. Two types of tests are available to diagnose a peptic ulcer. They are called upper endoscopy and upper gastrointestinal series.<\/p>\n

 <\/p>\n

\"\"<\/p>\n

Click here to learn more about the Peptic Ulcers Market Landscape<\/a><\/p>\n

The Report Covers the Peptic Ulcers Epidemiology Segmented by:<\/strong><\/p>\n